Search Results - "Sinnige, Harm A.M"

Chemotherapy, Bevacizumab, and Cetuximab in Metastatic Colorectal Cancer by Tol, Jolien, Koopman, Miriam, Cats, Annemieke, Rodenburg, Cees J, Creemers, Geert J.M, Schrama, Jolanda G, Erdkamp, Frans L.G, Vos, Allert H, van Groeningen, Cees J, Sinnige, Harm A.M, Richel, Dirk J, Voest, Emile E, Dijkstra, Jeroen R, Vink-Börger, Marianne E, Antonini, Ninja F, Mol, Linda, van Krieken, Johan H.J.M, Dalesio, Otilia, Punt, Cornelis J.A

“…Capecitabine, oxaliplatin, and bevacizumab are standard treatment for metastatic colorectal cancer. This trial tested whether adding cetuximab to this…”
Get full text

On the enhancement of efficiency in care for cancer patients in outpatient clinics: an instrument to accelerate psychosocial screening and referral by Pruyn, Jean F.A, Heule-Dieleman, Hélène A.G, Knegt, Paul P, Mosterd, Femke R, van Hest, Mariëlle A.G, Sinnige, Harm A.M, Pruyn, Ad Th.H, de Boer, Maarten F

“…Many cancer patients experience psychosocial problems that go unnoticed by caregivers. To improve this situation, an instrument has been developed and tested…”
Get full text

Improving the identification of frail elderly newly diagnosed multiple myeloma patients by Stege, Claudia A. M., Nasserinejad, Kazem, Klein, Saskia K., Timmers, Gert-Jan, Hoogendoorn, Mels, Ypma, Paula F., Nijhof, Inger S., Velders, Gerjo A., Strobbe, Leonie, Durdu-Rayman, Nazik, Westerman, Matthijs, Davidis-van Schoonhoven, Marjan A., van Kampen, Roel J. W., Beeker, Aart, Koster, Ad, Dijk, Amanda C., van de Donk, Niels W. C. J., van der Spek, Ellen, Leys, Rineke B. L., Silbermann, Matthijs H., Groen, Kaz, van der Burg-de Graauw, Nicole C. H. P., Sinnige, Harm A. M., van der Hem, Klaas G., Levenga, Henriette, Bilgin, Yavuz M., Sonneveld, Pieter, Levin, Mark-David, Zweegman, Sonja

Get full text

Case report: Coxiella burnetii vascular infection and lymphoma in the Netherlands by van Roeden, Sonja E., Melenotte, Cléa, Hermans, Mirjam H. A., Sinnige, Harm A. M., Nooijen, Peet T. G. A., Audoly, Gilles, Hoepelman, Andy I. M., Oosterheert, Jan Jelrik, Raoult, Didier, Wever, Peter C.

“…Objectives and design Non-Hodgkin lymphoma has been linked to infection with Coxiella burnetii , potentially through overproduction of IL-10 during infection…”
Get full text

Hepatosplenic T-cell lymphoma in a 47-year-old Crohn’s disease patient on thiopurine monotherapy by van de Meeberg, Maartje M, Derikx, Lauranne A A P, Sinnige, Harm A M, Nooijen, Peet, Schipper, D Lucette, Nissen, Loes H C

“…Hepatosplenic T-cell lymphoma(HSTCL) is a rare nonHodgkin lymphoma with a high mortality rate. Higher incidence is reported in patients with inflammatory bowel…”
Get full text

Clofarabine added to intensive treatment in adult patients with newly diagnosed ALL: the HOVON-100 trial by Rijneveld, Anita W., van der Holt, Bronno, de Weerdt, Okke, Biemond, Bart J., van de Loosdrecht, Arjen A., van der Wagen, Lotte E., Bellido, Mar, van Gelder, Michel, van der Velden, Walter J.F.M., Selleslag, Dominik, van Lammeren-Venema, Daniëlle, Halkes, Constantijn J.M., Fijnheer, Rob, Havelange, Violaine, van Sluis, Geerte L., Legdeur, Marie-Cecile, Deeren, Dries, Gadisseur, Alain, Sinnige, Harm A.M., Breems, Dimitri A., Jaspers, Aurélie, Legrand, Ollivier, Terpstra, Wim E., Boersma, Rinske S., Mazure, Dominiek, Triffet, Agnes, Tick, Lidwine W., Beel, Karolien, Maertens, Johan A., Beverloo, H. Berna, Bakkus, Marleen, Homburg, Christa H.E., de Haas, Valerie, van der Velden, Vincent H.J., Cornelissen, Jan J.

“…Clofarabine (CLO) is a nucleoside analog with efficacy in relapsed/refractory acute lymphoblastic leukemia (ALL). This randomized phase 3 study aimed to…”
Get full text

High-dose imatinib versus high-dose imatinib in combination with intermediate-dose cytarabine in patients with first chronic phase myeloid leukemia: a randomized phase III trial of the Dutch-Belgian HOVON study group by Thielen, Noortje, van der Holt, Bronno, Verhoef, Gregor E. G., Ammerlaan, Rianne A. H. M., Sonneveld, Pieter, Janssen, Jeroen J. W. M., Deenik, Wendy, Falkenburg, J. H. Frederik, Kersten, Marie José, Sinnige, Harm A. M., Schipperus, Martin, Schattenberg, Anton, van Marwijk Kooy, Rien, Smit, Willem M., Chu, Isabel W. T., Valk, Peter J. M., Ossenkoppele, Gert J., Cornelissen, Jan J.

“…Despite the revolutionary change in the prognosis of chronic myeloid leukemia (CML) patients with the introduction of imatinib, patients with resistant disease…”
Get full text

Remission of a primary thyroid lymphoma after methotrexate withdrawal by De Mast, Quirijn, Haverman, Joost, Netten, Paetrick M., Sinnige, Harm A. M.

Get full text

5-Fluorouracil/leucovorin/interferon alpha-2a in patients with advanced colorectal cancer. Effects of maintenance therapy on remission duration by Buter, J, Sinnige, H A, Sleijfer, D T, de Vries, E G, Willemse, P H, van der Graaf, W T, Verschueren, R C, Mulder, N H

“…A Phase II study of combination treatment with 5-fluorouracil (5-FU), leucovorin (LV), and interferon alpha-2a (IFN) in patients with previously untreated…”
Get more information

A phase I-II study of 14-days continuous infusion of 5-fluorouracil with weekly bolus leucovorin in metastatic colorectal carcinoma by Sinnige, H A, Nanninga, A G, Verschueren, R C, Sleijfer, D T, de Vries, G E, Willemse, P H, Mulder, N H

“…A consecutive phase I and phase II study of a 14-days continuous infusion schedule of 5-fluorouracil with weekly bolus injection leucovorin was performed in 10…”
Get more information

Modification of 5-fluorouracil activity by high-dose methotrexate or leucovorin in advanced colorectal carcinoma by Sinnige, H A, Sleijfer, D T, de Vries, E G, Willemse, P H, Mulder, N H

“…21 patients with advanced colorectal carcinoma were entered into a phase II study to evaluate efficacy and toxicity of methotrexate (MTX), 1500 mg/m2 rapid…”
Get more information